[go: up one dir, main page]

AU2003209544A8 - Use of mycobacterium w in the treatment of asthama(obstructive lung disease) - Google Patents

Use of mycobacterium w in the treatment of asthama(obstructive lung disease)

Info

Publication number
AU2003209544A8
AU2003209544A8 AU2003209544A AU2003209544A AU2003209544A8 AU 2003209544 A8 AU2003209544 A8 AU 2003209544A8 AU 2003209544 A AU2003209544 A AU 2003209544A AU 2003209544 A AU2003209544 A AU 2003209544A AU 2003209544 A8 AU2003209544 A8 AU 2003209544A8
Authority
AU
Australia
Prior art keywords
asthama
mycobacterium
treatment
lung disease
obstructive lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209544A
Other versions
AU2003209544A1 (en
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003209544A8 publication Critical patent/AU2003209544A8/en
Publication of AU2003209544A1 publication Critical patent/AU2003209544A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003209544A 2002-03-13 2003-03-11 Use of mycobacterium w in the treatment of asthama(obstructive lung disease) Abandoned AU2003209544A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN246MU2002 2002-03-13
IN246/MUM/2002 2002-03-13
PCT/IB2003/000866 WO2003075827A2 (en) 2002-03-13 2003-03-11 Use of mycobacterium w in the treatment of asthama(obstructive lung disease)

Publications (2)

Publication Number Publication Date
AU2003209544A8 true AU2003209544A8 (en) 2003-09-22
AU2003209544A1 AU2003209544A1 (en) 2003-09-22

Family

ID=27799870

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003209544A Abandoned AU2003209544A1 (en) 2002-03-13 2003-03-11 Use of mycobacterium w in the treatment of asthama(obstructive lung disease)

Country Status (3)

Country Link
AU (1) AU2003209544A1 (en)
BR (1) BR0303387A (en)
WO (1) WO2003075827A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2464231B (en) * 2006-11-23 2010-08-04 Cadila Pharmaceuticals Ltd Poly-TLR antagonist
WO2009001204A2 (en) * 2007-06-28 2008-12-31 Cadila Pharmaceuticals Ltd. Mitogen activated protein kinase modulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4422859C2 (en) * 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Aqueous cell extracts from mycobacteria

Also Published As

Publication number Publication date
WO2003075827A3 (en) 2003-12-24
AU2003209544A1 (en) 2003-09-22
WO2003075827A2 (en) 2003-09-18
BR0303387A (en) 2004-07-20

Similar Documents

Publication Publication Date Title
AU2003228445A8 (en) Tissue composites and uses thereof
SI1572095T1 (en) Beta-l-2'-deoxynucleosides for use in the treatment of resistant hbv strains
SI1530466T1 (en) Use of Nintedanib for the treatment of lung fibrosis
PL372928A1 (en) Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
GB0201674D0 (en) Medical treatment
GB0218879D0 (en) Medical treatment
GB0213869D0 (en) The treatment of pain
IL164078A0 (en) Treatment of lung disorder
SG106109A1 (en) Tomography or curved surfaces
GB0219660D0 (en) Therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003209544A8 (en) Use of mycobacterium w in the treatment of asthama(obstructive lung disease)
EP1450831A4 (en) Methods of treatment in situ in the lungs of mammals
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
IL164951A0 (en) The treatment of pain with lfendropil
GB0201025D0 (en) The treatment of degenerative diseases
GB2392839A8 (en) Use of Mycobacterium w in the treatment of tubercolosis
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
AU2003217432A8 (en) Angiopoietin-1 in the treatment of disease
HRP20041159A2 (en) Combination for the treatment of airway disorders
AU2003297912A8 (en) Methods for screening compounds for use in the treatment of disease
AU2003245674A8 (en) Oral disease prevention and treatment
GB0121046D0 (en) The diagnosis and treatment of airways disease
GB0216978D0 (en) The treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase